中国医学前沿杂志(电子版)
中國醫學前沿雜誌(電子版)
중국의학전연잡지(전자판)
CHINESE JOURNAL OF THE FRONTIERS OF MEDICAL SCIENCE(ELECTRONIC VERSION)
2015年
4期
32-35
,共4页
古丽赛娜木·艾合买提%阿里木·帕塔尔%买买提艾力·吾布力%潘珂君%张跃新
古麗賽娜木·艾閤買提%阿裏木·帕塔爾%買買提艾力·吾佈力%潘珂君%張躍新
고려새나목·애합매제%아리목·파탑이%매매제애력·오포력%반가군%장약신
艾滋病%抗病毒治疗%疗效
艾滋病%抗病毒治療%療效
애자병%항병독치료%료효
AIDS%Anti-retroviral therapy%Efifcacy
目的综合评价高效抗逆转录病毒治疗效果,为改善抗病毒治疗工作提供科学依据。方法回顾性分析接受高效抗逆转录病毒治疗的482例艾滋病患者CD4+T淋巴细胞计数、病毒载量的变化、机会性感染发生情况以及死亡原因等。结果482例艾滋病患者的平均年龄为(35.7±11.0)岁,多为男性[318例(66.0%)];337例(69.9%)为维吾尔族,感染途径以性接触(60.7%)为主。CD4+T淋巴细胞水平在治疗3、18、24个月后均明显上升,与治疗前相比差异具有显著性(P<0.05);至2014年6月,继续接受随访的240例患者中,病毒完全抑制例数达182例(75.8%)。机会性感染发生率为57.1%(275/482),主要以鹅口疮[31.3%(86/275)]为主。482例患者死亡65例(13.5%),死因以呼吸衰竭为主。结论高效抗逆转录病毒治疗艾滋病的临床效果较好。
目的綜閤評價高效抗逆轉錄病毒治療效果,為改善抗病毒治療工作提供科學依據。方法迴顧性分析接受高效抗逆轉錄病毒治療的482例艾滋病患者CD4+T淋巴細胞計數、病毒載量的變化、機會性感染髮生情況以及死亡原因等。結果482例艾滋病患者的平均年齡為(35.7±11.0)歲,多為男性[318例(66.0%)];337例(69.9%)為維吾爾族,感染途徑以性接觸(60.7%)為主。CD4+T淋巴細胞水平在治療3、18、24箇月後均明顯上升,與治療前相比差異具有顯著性(P<0.05);至2014年6月,繼續接受隨訪的240例患者中,病毒完全抑製例數達182例(75.8%)。機會性感染髮生率為57.1%(275/482),主要以鵝口瘡[31.3%(86/275)]為主。482例患者死亡65例(13.5%),死因以呼吸衰竭為主。結論高效抗逆轉錄病毒治療艾滋病的臨床效果較好。
목적종합평개고효항역전록병독치료효과,위개선항병독치료공작제공과학의거。방법회고성분석접수고효항역전록병독치료적482례애자병환자CD4+T림파세포계수、병독재량적변화、궤회성감염발생정황이급사망원인등。결과482례애자병환자적평균년령위(35.7±11.0)세,다위남성[318례(66.0%)];337례(69.9%)위유오이족,감염도경이성접촉(60.7%)위주。CD4+T림파세포수평재치료3、18、24개월후균명현상승,여치료전상비차이구유현저성(P<0.05);지2014년6월,계속접수수방적240례환자중,병독완전억제례수체182례(75.8%)。궤회성감염발생솔위57.1%(275/482),주요이아구창[31.3%(86/275)]위주。482례환자사망65례(13.5%),사인이호흡쇠갈위주。결론고효항역전록병독치료애자병적림상효과교호。
Objective To evaluate the treatment effect of AIDS cases with highly active anti-retroviral therapy, provide scientiifc evidence for effective antiviral therapy treatment. Method CD4 +T lymphocyte count, changes of the viral load, incidence of opportunistic infections and cause of death in 482 AIDS patients who received highly active anti-retroviral therapy were retrospectively analyzed. Result The average age of 482 AIDS patients were (35.7±11.0) years old, most were men [318 cases (66.0%)], 337 cases (69.9%) were Uyghur ethnic, HIV infection occurred mainly via sexual contact (60.7%). CD4+T lymphocyte counts increased signiifcantly after treatment for 3, 18, 24 months. There were statistically signiifcant differences in the detection results of CD4+T lymphocyte count between the pre-treatment and the post-treatment for 3, 18 and 24 months (P<0.05). 75.8%patients with the therapy efifciency. Opportunistic infections rate was 57.1%(275/482), most was thrush [31.3%(86/275)]. Fractures mortality was 13.5%, respiratory failure was the primary cause of death. Conclusion It is effective to carry out highly active anti-retroviral therapy on AIDS patients.